United States: A recent report indicates that liver diseases affecting about 40 percent of American adults may escalate to severe problems, leading to fatal results.
More about the news
Healthcare providers identify fatty liver disease through its other name, while patients frequently reach the stage of liver cirrhosis before doctors make a correct diagnosis.
Doctors previously had limited intervention opportunities through recommendations about diet changes and lifestyle modifications and management help for associated conditions such as diabetes and high cholesterol.
The implemented strategies have proven insufficient to deliver satisfactory results, the New York Times reported.
Research about weight-loss surgery reveals its potential to stop severe health complications from happening to patients considering cirrhosis.
Men with fatty liver disease lost more weight when using olive pomace oil instead of seed oils. The more linoleic acid in the diet, the less weight loss. pic.twitter.com/qpoj8b6hpH
— Master Metabolism (@lowmegatron) February 11, 2025
What more has the study indicated?
The published study appearing in Nature Medicine evaluated patients suffering from obesity and cirrhosis because of metabolically misbehaving steatohepatitis known as MASH.
MASH develops as a significant medical problem among patients who are obese. Patients who underwent bariatric surgery at year 15 faced major liver cancer complications at rates 72 percent lower than patients without bariatric procedures.
Doctors now display hope because research findings collaborate with emerging studies about weight-loss drugs that assist in treating fatty liver disease.
The disease progress of MASH starts with liver tissue accumulating excessive fat. The continuous pathology produces liver inflammation that eventually makes the organ develop fibrosis and scarring.
Medical evidence proves that substantial weight reduction accomplishes both the restoration of fibrosis and enhanced long-term outcomes for patients.
According to Dr. Rotonya Carr, who is the division head of gastroenterology at the University of Washington, “Most people assume that cirrhosis is a death sentence,” the New York Times reported.
Researchers conducted minimal studies into cirrhosis at that time. Researchers from the Cleveland Clinic examined medical records to identify 168 adult patients with an obesity body mass index of 30 or higher who had cirrhosis because of MASH.
The research only studied patients who maintained compensated cirrhosis status without severe complications advancing from this condition.